Bringing a new drug to market costs between $985 million and $1.3 billion — and 70% of that investment goes to clinical trials. For GSK, one of the world's largest pharmaceutical companies with 70+ candidates in their pipeline, managing clinical trial resources across continents isn't just complex. It's a billion-dollar optimization problem.
Clinical trials span three phases, each with dramatically different resource requirements. Phase I might need 50 patients for 28 months. Phase III requires hundreds or thousands of participants across multiple countries for 38+ months. Staff, facilities, equipment, patient recruitment, regulatory compliance — the variables multiply exponentially when you're running trials worldwide.
GSK's resource data lived in silos: SAP BusinessObjects for enterprise planning, Siebel for customer and site management, Cognos for business intelligence, and Oracle for data warehousing. Without integration, planners couldn't answer basic questions: Do we have enough clinical research associates for next quarter's Phase III expansion? What happens if enrollment accelerates? What if a trial site underperforms?